Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
5
×
boston top stories
life sciences
national blog main
national top stories
biotech
clinical trials
startups
boston
deals
glaxosmithkline
new york
new york blog main
new york top stories
san francisco blog main
20/20 healthcare partners
abbvie
acorda therapeutics
allergan
allosteric
alnylam pharmaceuticals
amgen ventures
ampyra
amyotrophic lateral sclerosis
anthony despasqua
apokyn
apomorphine
atlas venture
atopic dermatitis
autoimmune disorders
beijing
brace pharma
brii bio
brii biosciences
bristol-myers squibb
china
christian angermayer
cleva pharma
clinical data
dalfampridine
What
disease
5
×
new
5
×
drug
adds
approved
medicines
working
acorda
address
ago
alliance
allosteric
areas
associated
biosciences
bio’s
brii
clinic
companies
cope
data
develop
device
dialysis
diseases
drugs
earlier
elusive
enclear
episodes
fatty
fda
friday
gets
harmful
help
hepatitis
horizon
hotspot
infectious
Language
unset
Current search:
disease
×
new
×
" boston blog main "
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
